Today, the @US_FDA granted Fast Track Designation to our investigational therapy for the treatment of relapsed or refractory #myelofibrosis. Updated data were presented today at the @European Hematology Association (EHA) 2025 Congress. #EHA2025 https://t.co/DoZvoXYADP

Happy Thanksgiving from all of us at SMPA! We’re grateful for our colleagues, partners and the patients who inspire our work every day. Wishing everyone a healthy and safe holiday season. #SumitomoLife

This #Movember is a great time to speak with your healthcare provider about getting screened for prostate cancer. Your level of risk may guide what screening measures may be right for you based on your age. #Movember #MensHealth

On #VeteransDay, we honor the strength and sacrifice of those who have served. Thank you to all veterans, including our SMPA colleagues, for your dedication and leadership. #SumitomoLife

This #NationalFamilyCaregiversMonth, we honor the compassion and strength of caregivers everywhere. Their support is vital to patients’ journeys, and they inspire our work to deliver meaningful innovation. #SumitomoLife

Happy Halloween from all of us at SMPA! Wishing our colleagues, partners and communities a fun, festive and safe holiday. #SumitomoLife

This #LGBTQIA+HistoryMonth, we celebrate the history, resilience and achievements of the LGBTQ+ community and honor the diverse perspectives that fuel SMPA’s innovation. #SumitomoLife

Period Action Day is a global call to break stigma and end period poverty. Menstrual health is health--and open conversations are key to building equity. #SumitomoLife

This #DepressionAwarenessMonth, we raise awareness, break stigma and support those living with depression. Together, we can help ensure no one feels alone in their journey. #SumitomoLife

Prostate cancer affects millions of men and the people who stand by them. But the emotional side of the journey is often overlooked. This September, let’s remind one another that community, connection, and compassion are important.

Did you know that about 1 in 8 men will be diagnosed with prostate cancer during their lifetimes? We encourage you to wear blue this month to support prostate cancer patients, and speak with your healthcare provider about when you should get screened.

Have you spoken with your healthcare provider about getting screened for prostate cancer? Your level of risk may guide what screening measures may be right for you based on your age. #ProstateCancerAwarenessMonth #MensHealth

This #SuicidePreventionWeek, we raise awareness, break stigma and encourage open conversations about mental health. If you or someone you know is struggling, call or text 988 for free, confidential support 24/7. #SumitomoLife

Each year, millions of newborns in the U.S. are screened for rare but serious conditions present at birth—enabling early diagnosis and care that can save lives. This #NewbornScreeningAwarenessMonth, we spotlight the importance of screening to protect babies and families.

September is Prostate Cancer Awareness Month, and SMPA recognizes men living with the disease – you are not alone. In addition, now is the time to educate yourself about prostate cancer and support those who are affected. #ProstateCancerAwarenessMonth #MensHealth

On #LaborDay, we celebrate the dedication of our colleagues, partners and communities. Wishing you a safe and restful holiday. #SumitomoLife

On #WomensEqualityDay, SMPA recognizes the brilliant women leaders and scientists who pave the way for progress. Their legacy fuels our commitment to advancing gender equity and fostering a culture of inclusion and opportunity. #womensequality

At Sumitomo Pharma America, patients are at the heart of all we do. From the lab to the market, we pursue innovation across a range of therapeutic areas to make a difference in people’s lives. Check out our current opportunities: https://t.co/jt8CjV7kKS

This #NationalImmunizationAwarenessMonth, Sumitomo Pharma America highlights the importance of vaccination for people of all ages. Talk to your healthcare provider to ensure you’re up to date on all of your vaccines!

Sumitomo Pharma America is happy to share that the EMA has granted Orphan Drug Designation to our investigational therapy for relapsed or refractory #myelofibrosis. Read more: https://t.co/dlTlW0MCW4

Do you or someone in your network have a passion for collaboration, innovation and delivering life-changing treatments on behalf of patients? Explore SMPA’s open positions: https://t.co/nyoALlXhU3 #We’reHiring #SumitomoLife